ICER President: Remdesivir Price was ‘Responsible’ Decisions
The Institute for Clinical and Economic Review's president, Steven Pearson, says Gilead's decision to price its COVID-19 treatment remdesivir at [...]
Article Proposes New Framework for Patient Engagement
A recent article published in the Journal of Comparative Effectiveness Research puts forth a new framework for patient engagement in [...]
ASH Outlines Ins and Outs of Cost-Effective Analyses
In its cover article for the March edition of the ASH Clinical News magazine, ASH takes a deep dive into [...]
ICER Launches New Suite of Interactive Tools
The Institute for Clinical and Economic Review (ICER) recently announced a new set of interactive tools that could serve as [...]
Pearson: Program to Bolster Patient Involvement in Review Process
The Institute for Clinical and Economic Review's (ICER) new Patient Engagement Program is a big leap forward for the drug [...]
Advertisement
